ACCEL Lite: Featured ACCEL Interview With Nanette Wenger and Deepak Bhatt
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Release Date: 02/27/2019
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Aortic valve disease is often identified too late before clinicans can provide meaningful prevention. Identifying aortic valve calcium opens the door for potential prevention of progression: a phenotype researchers could build randomized controlled trials around. In this interview, Richard A. Chazal MD, MACC and Michael J. Blaha, MD, MPH discuss Prevalence of Aortic Valve Calcium and the Long-Term Risk of Incident Severe Aortic Stenosis. Podcasts |
info_outline From JACC: Low-Density Lipoprotein Cholesterol Testing Following MI Hospitalization Among Medicare BeneficiariesACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
After a heart attack, it is important to lower cholesterol levels to prevent future heart attacks. Monitoring cholesterol levels on treatment is just as important as monitoring blood pressure levels on treatment to make sure that the medicines are having the desired effect. In this interview, C. Noel Bairey Merz, MD, FACC, and Vera Bittner, MD, MSPH, FACC, discuss Low-Density Lipoprotein Cholesterol Testing Following MI Hospitalization Among Medicare Beneficiaries. Podcasts |
info_outline JACC State-of-the-Art Review: Racial and Ethnic Disparities in Perioperative Health Care Among Patients Undergoing Cardiac SurgeryACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
This episode covers a review on disparities in cardiovascular perioperative health care. The writers propose actionable solutions utilizing multidisciplinary perspectives from cardiology, cardiac surgery, cardiothoracic anesthesiology, critical care, medical ethics, and health disparity experts. In this interview, Adam J. Milam, MD, PhD, and Clyde W.Yancy, MD, MSc, MACC, discuss the JACC State-of-the-Art Review: Racial and Ethnic Disparities in Perioperative Health Care Among Patients Undergoing Cardiac Surgery. Podcasts | |
info_outline From JACC: National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and CostsACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Cardiac imaging is increasingly used in the workup of coronary artery disease, with growth greatest for CCTA and with falling use of SPECT. Because of the low cost of computed tomography, this growing use of imaging has had only a small impact on cost of provision of diagnostic imaging in this population. In this interview, Jonathan R. Weir-McCall, PhD, and Christopher M. Kramer, MD, FACC, discuss From JACC: National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs. Podcasts | |
info_outline ACCEL Lite: Top Takeaways from the AFib GuidelinesACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
In this interview, José A. Joglar, MD, FACC, and Joseph E. Marine MD, MBA, FACC, discuss the top takeaways from the latest atrial fibrillation (AFib) guideline, which provides new and updated recommendations for preventing and optimally managing AFib. Podcasts | |
info_outline ACCEL Lite: From JACC: Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac DeathACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
A study provides new data for patients with genetic heart disease (GHD) and exercise recommendations. For decades, those with GHD were excluded from exercise and sports participation. This has led to poor exercise tolerance, increased risk for CAD and poor outcomes in this group related to reduced fitness. This study helps frame that those with GHD are unique and as a result, require an individualized approach to care. After expert consultation, patients with GHD can often be safe to participate in exercise including competitive sports. This is a first step in the direction of...
info_outline AHA Late-Breaker ARTESiA: Apixaban for the Prevention of Stroke in Patients With Subclinical AFACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Continuous cardiac monitoring detects brief, asymptomatic, heart rhythm abnormalities in one-third of older individuals and these symptoms are associated with an increased risk of stroke. The ARTESiA trial clearly demonstrates that use of the blood thinner apixaban reduces patient risk of stroke compared to treatment with aspirin, but is associated with an increased risk of bleeding. In this interview, Jeff S. Healey, MD, and Thomas F. Deering MD, FACC, discuss AHA Late-Breaker: Apixaban for the Prevention of Stroke in Patients With Subclinical Atrial Fibrillation. ...
info_outline ACCEL Lite: Behind the ACC 2023 Guideline for Chronic CAD: Conversations and ControversiesACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
The 2023 guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease, considering social determinants of health and incorporating the principles of shared decision-making and team-based care. In this interview, Kristin Newby, MD, FACC, and Nanette Kass Wenger MD, MACC, discuss Behind the ACC 2023 Guideline for Chronic CAD: Conversations and Controversies. Podcasts | |
info_outline ACCEL Lite: Top Takeaways from the ACC 2023 Guideline for Chronic CAD for the Practicing ClinicianACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
To improve our understanding of the basic principles in the treatment and management of patients with chronic heart disease, in this interview, Salim S. Virani, MD, PhD, FACC, and Roger S. Blumenthal, MD, FACC, discuss top takeaways from the ACC 2023 Guideline for Chronic CAD. Podcasts | |
info_outline ACCEL Lite: Management of Worsening Heart Failure with Reduced Ejection FractionACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Patients with worsening heart failure are at an extraordinarily high risk for mortality and readmission. Early identification and optimal management of these patients can significantly improve patient outcomes. Several clinical trials in these patients have shown benefit with various therapies. In this interview, Javed Butler, MD, MPH, MBA, FACC, and Matthew Martinez, MD, FACC, discuss Management of Worsening Heart Failure with Reduced Ejection Fraction. Podcasts | |
info_outlineIn this interview, Nanette Wenger and Deepak Bhatt discuss the Primary Results of REDUCE-IT (Reduction of Cardiovascular Events With Icosapent Ethyl–Intervention Trial).